Cat. No.: X24-08-YM447
PPAR inhibitor, CDDO-Im, Purity ≥98%
Synonym: 443104-02-7; RTA-403; TP-235; CDDO-Imidazolide; (4aR,6aR,6aS,6bR,8aS,12aS,14bS)-8a-(Imidazole-1-carbonyl)-4,4,6a,6b,11,11,14b-heptamethyl-3,13-dioxo-4a,5,6,6a,7,8,9,10,12,12a-decahydropicene-2-carbonitrile
- CAS Number: 443104-02-7
- Compound CID: 9958995
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
CDDO-Im, soluble in DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting PPAR. It targets the PPARα and PPARγ.
Molecular Formula
C34H43N3O3
Targets
PPARα: 232 nM (Ki); PPARγ: 344 nM (Ki)
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 48 mg/mL (88.6 mM); Water: insoluble; Ethanol: insoluble
Applications
CDDO-Im is a metabolism inhibitor that can be used for its anti-inflammatory and anti-cancer properties.
Related Products
- VCE-004.8
- PPAR inhibitor, Fenofibrate, Purity ≥98%
- PPAR inhibitor, Gemfibrozil, Purity ≥98%
- PPAR inhibitor, 5-Aminosalicylic acid, Purity ≥98%
- PPAR inhibitor, Rosiglitazone, Purity ≥98%
- PPAR inhibitor, Rosiglitazone maleate, Purity ≥98%
